Uri Elmaliach - Brainsway Director
| BRIN Stock | 960.00 5.10 0.53% |
Director
Dr. Uri Elmaliach serves as Director at Brainsway Ltd since December 20, 2006. He is a member of the Company Audit Committee. Previously, he worked at Rad Biomed Accelerator Ltd since 2006.
| Age | 65 |
| Tenure | 18 years |
| Professional Marks | Ph.D |
| Phone | 972 2 5813140 |
| Web | www.brainsway.com |
Similar Executives
| Found 11 records | DIRECTOR Age | ||
| Michal Preminger | Compugen | N/A | |
| Eran Perry | Compugen | N/A | |
| Gilead Halevy | Compugen | 51 | |
| Ruth Arnon | Compugen | 86 | |
| Arie Ovadia | Compugen | 67 | |
| Kinneret Savitsky | Compugen | 50 | |
| Yair Aharonowitz | Compugen | 73 | |
| Joshua Shemer | Compugen | 63 | |
| Sanford Zweifach | Compugen | 60 | |
| JeanPierre Bizzari | Compugen | 64 | |
| Dov Hershberg | Compugen | 74 | |
Brainsway Leadership Team
Elected by the shareholders, the Brainsway's board of directors comprises two types of representatives: Brainsway inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brainsway. The board's role is to monitor Brainsway's management team and ensure that shareholders' interests are well served. Brainsway's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brainsway's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gavriel Magen, Director | ||
| Avraham Posen, Director of Global Sales | ||
| Uri Elmaliach, Director | ||
| Rami Itselev, Internal Auditor | ||
| Daniel Azriel, Director | ||
| Karen Sarid, Director | ||
| David Zacut, Chairman of the Board | ||
| Ety Rayten, External Director | ||
| Daniel Azriely, Director | ||
| Yuval Lavi, Director | ||
| Amit Jino, Clinical Experiment Coordinator | ||
| Hila Rubinshtein, Managing Director of Quality Control | ||
| Giora Yanay, Director | ||
| Ofra Hackelman, COO | ||
| Yosef Shalom, Director | ||
| Avner Hagai, Founder and President and Director | ||
| Yiftach Roth, Founder, Chief Scientist and Director | ||
| Yael Ziger, CFO | ||
| Orly Uri, External Director | ||
| Ronen Segal, VP of RandD | ||
| Guy Ezekiel, President CEO | ||
| Yaacov Michlin, Director | ||
| Eynat Tsafrir, External Director |
Brainsway Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brainsway a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| EBITDA | (3.89 M) | |||
| Cash And Equivalents | 9.07 M | |||
| Cash Per Share | 0.55 X | |||
| Total Debt | 2.83 M | |||
| Debt To Equity | 40.70 % | |||
| Current Ratio | 1.62 X | |||
| Book Value Per Share | 0.42 X | |||
| Cash Flow From Operations | (3.77 M) | |||
| Earnings Per Share | (0.39) X | |||
| Number Of Employees | 96 |
Pair Trading with Brainsway
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brainsway position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainsway will appreciate offsetting losses from the drop in the long position's value.Moving together with Brainsway Stock
| 0.73 | BOLT | BioLight Life Sciences | PairCorr |
Moving against Brainsway Stock
| 0.75 | PSTI | Pluristem | PairCorr |
| 0.73 | PRTC | Priortech | PairCorr |
| 0.52 | GPGB | GP Global Power | PairCorr |
| 0.41 | APLP | Apollo Power | PairCorr |
The ability to find closely correlated positions to Brainsway could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brainsway when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brainsway - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brainsway to buy it.
The correlation of Brainsway is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brainsway moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brainsway moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brainsway can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainsway. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Brainsway Stock refer to our How to Trade Brainsway Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Brainsway Stock analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |